Alcon lens payment boost
This article was originally published in The Gray Sheet
Executive Summary
CMS grants Alcon AcrySof IQ intraocular lens a new technology IOL classification, effective May 19. The $50 bonus payment for cataract surgery with the lens remains in effect for five years. According to Alcon, CMS based its decision on evidence that AcrySof IQ has "the same or greater clinical benefit" as Advanced Medical Optics' Tecnis IOL, the first lens to receive the new tech classification (1"The Gray Sheet" Jan. 30, 2006, In Brief)...
You may also be interested in...
B&L lens payment bonus
Bausch & Lomb's SofPort AO and SofPort AO with Violet Shield intraocular lenses receive new technology IOL designations from CMS, effective March 6. Joining lenses from AMO (Tecnis and Tecnis CL) and Alcon (AcrySof IQ), Bausch & Lomb's IOLs will now also receive a $50 Medicare bonus payment when used in cataract procedures performed in ambulatory surgical centers through Feb. 27, 2011. The three firms' lenses reduce spherical aberrations for better vision quality relative to standard IOLs (1"The Gray Sheet" May 29, 2006, In Brief)...
AMO gets improved IOL payments
Advanced Medical Optics' Tecnis foldable intraocular lens receives a new technology IOL designation from CMS, becoming the only lens to currently qualify for the $50 bonus payment per lens for procedures performed in ambulatory surgical centers. In granting the payment, CMS agreed with FDA labeling claims that Tecnis reduces postoperative spherical aberrations and improves night driving compared to lenses with spherical optics (1"The Gray Sheet" Dec. 5, 2005, p. 7). The bonus payments, which will last for five years, will go into effect Feb. 27...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”